iNtRON Biotechnology Inc
iNtRON Biotechnology Inc ProductsSince its foundation, iNtRON Biotechnology has continuously invested in research and development, significantly accelerating its innovation pace following its IPO on KOSDAQ.
The company aims to become a global R&D-driven enterprise, enhancing its value through the development of innovative BIO new drugs, including multiple first-in-class biologics, and by conducting clinical studies across various phases.
LiliF® is a specialized trademark of iNtRON Bio’s Diagnostics (DR) business division, under which the company develops diagnostic kits for a wide range of diseases.
In parallel, iNtRON Bio strengthens its global presence by focusing on Diagnostics, Biological Resources, and Molecular Reagents, supported by a robust manufacturing infrastructure. Its production system is certified under ISO 9001, ISO 14001, ISO 13485, and GMP, ensuring consistent product quality and reliable manufacturing standards.